GF
ORGO icon

Gabelli Funds’s Organogenesis Holdings ORGO Stock Holding History

Gabelli Funds’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,575
Closed -$96K – 1244
2022
Q3 		$96K Buy
29,575
+4,215
+17% +$19K ﹤0.01% 1207
2022
Q2 		$124K Hold
25,360
– – ﹤0.01% 1228
2022
Q1 		$193K Buy
25,360
+15,000
+145% +$116K ﹤0.01% 1249
2021
Q4 		$96K Buy
+10,360
New +$110K ﹤0.01% 1306

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Gabelli Funds's ORGO Position: Q4 2022 in Review

Gabelli Funds sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 29,575 shares — an estimated $96K sold.

Gabelli Funds first reported a position in ORGO in Q4 2021 and held it in 4 quarters. The position peaked at $193K in Q1 2022. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Gabelli Funds reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Gabelli Funds sold 29,575 Organogenesis Holdings shares in Q4 2022, an estimated $96K.
  • Gabelli Funds first reported a position in Organogenesis Holdings in Q4 2021 and held it in 4 quarters.
  • Gabelli Funds's Organogenesis Holdings position peaked at $193K in Q1 2022.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.